An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries

Background: Policy makers face a lot of challenges in the process of drug reimbursement decision making, especially in the context of entering the market of more and more innovative medicinal products. The aim of the current study is to make an overview of the reimbursement system development and to evaluate the access of innovative medicines, which have entered the EU market in the period 2015-2017, in Bulgaria as a reference example for the...